Articles
The 12th Annual Summit of the Association of Value-Based Cancer Care (AVBCC) in 2022 was the site of an encouraging and positive trend that is taking on more prominence in US healthcare: recognition, discussion of, and intervention around social determinants of health (SDoH). Although the concept that SDoH has an identifiable and actionable influence on health is not new, there are clear signs that thinking is moving more broadly beyond something we are considering to something we can actually use to improve healthcare.
Read More
Read More
On August 16, 2022, President Biden signed the Inflation Reduction Act into law, marking the first time the US Government will place direct price controls on many drugs covered by Medicare. The Medicare Part D benefit will also be restructured, and an annual patient out-of-pocket cap will be introduced.
Read More
Read More
By Wayne Kuznar
At the 12th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2022, held October 19-21, 2022, in New York City, a panel of experts from Upstream Partners discussed the current state of value-based agreements (VBAs) in pharma and what lies ahead. The session was moderated by Burt Zweigenhaft, PhD, DLitt, Executive Director and Co-Founder of AVBCC.
Read More
Read More
By Wayne Kuznar
Community-based providers remain at the core of the oncology care delivery system. A panel moderated by Barbara McAneny, MD, Chief Executive Officer, New Mexico Oncology Hematology Consultants, Albuquerque, at the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021 explored the road ahead for community practices in terms of balancing value and delivering optimal access to care for patients.
Read More
Read More
By Wayne Kuznar
By Wayne Kuznar
The success of oncology support services developed by pharmaceutical manufacturers depends on tailoring programs that meet the needs of their specific patient populations, said panelists at a roundtable discussion on patient centricity and connectivity in oncology support and HUB services.
Read More
Read More
By Wayne Kuznar
By Wayne Kuznar
By William King
t the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021, a panel of experts, moderated by Michael Reff, RPh, MBA, Founder and Executive Director, National Community Oncology Dispensing Association (NCODA), Cazenovia, NY, discussed the current and future state of Medically Integrated Pharmacy (MIP) and the benefits of this approach in oncology.
Read More
Read More
By Wayne Kuznar